drug toxicity testing
Researchers described the variant, disease, drug target, and drug safety insights being gained analyzing more than 150,000 UK Biobank whole-genome sequences.
Since the commercial launch of its technology last year, the firm has been validating it in studies with academic groups and pharmaceutical companies.
The system relies on the use of scannable safety code cards containing patient data, along with a web portal and automated analysis tools that deliver customized diagnostic reports.
The CATCH-KB database is a standardized variant repository meant to support new research into prevention of chemotherapy-induced cardiotoxicity.
The company's Ligand Express software combines biological, chemical, and protein structure data to identify candidate molecules for further research and development.